Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Research and standardization in Alzheimer's trials: reaching international consensus.

Carrillo MC, Rowe CC, Szoeke C, Masters CL, Ames D, O'Meara T, Macaulay SL, Milner A, Ellis KA, Maruff P, Rainey-Smith SR, Martins RN, Bain LJ, Head RJ; NIA/Alzheimer Association and International Working Group.

Alzheimers Dement. 2013 Mar;9(2):160-8. doi: 10.1016/j.jalz.2012.10.006. Epub 2012 Dec 23.

PMID:
23266004
2.

Biomarkers of Alzheimer disease.

Growdon JH.

Arch Neurol. 1999 Mar;56(3):281-3. Review.

PMID:
10190817
3.

Perspective on future role of biological markers in clinical therapy trials of Alzheimer's disease: a long-range point of view beyond 2020.

Hampel H, Lista S, Teipel SJ, Garaci F, Nisticò R, Blennow K, Zetterberg H, Bertram L, Duyckaerts C, Bakardjian H, Drzezga A, Colliot O, Epelbaum S, Broich K, Lehéricy S, Brice A, Khachaturian ZS, Aisen PS, Dubois B.

Biochem Pharmacol. 2014 Apr 15;88(4):426-49. doi: 10.1016/j.bcp.2013.11.009. Epub 2013 Nov 22. Review.

PMID:
24275164
4.
5.

Use of biomarkers and imaging to assess pathophysiology, mechanisms of action and target engagement.

Hampel H, Lista S.

J Nutr Health Aging. 2013 Jan;17(1):54-63. doi: 10.1007/s12603-013-0003-1.

PMID:
23299381
6.

The impact of cerebrospinal fluid biomarkers on the diagnosis of Alzheimer's disease.

Engelborghs S, Le Bastard N.

Mol Diagn Ther. 2012 Jun 1;16(3):135-41. doi: 10.2165/11634170-000000000-00000.

PMID:
22646065
7.

The future of Alzheimer's disease: the next 10 years.

Hampel H, Prvulovic D, Teipel S, Jessen F, Luckhaus C, Frölich L, Riepe MW, Dodel R, Leyhe T, Bertram L, Hoffmann W, Faltraco F; German Task Force on Alzheimer's Disease (GTF-AD).

Prog Neurobiol. 2011 Dec;95(4):718-28. doi: 10.1016/j.pneurobio.2011.11.008. Epub 2011 Nov 22. Review.

PMID:
22137045
8.

Biomarkers for Alzheimer's disease.

Sonnen JA, Keene CD, Montine KS, Li G, Peskind ER, Zhang J, Montine TJ.

Expert Rev Neurother. 2007 Aug;7(8):1021-8. Review.

PMID:
17678497
9.

Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative.

Vanderstichele H, Bibl M, Engelborghs S, Le Bastard N, Lewczuk P, Molinuevo JL, Parnetti L, Perret-Liaudet A, Shaw LM, Teunissen C, Wouters D, Blennow K.

Alzheimers Dement. 2012 Jan;8(1):65-73. doi: 10.1016/j.jalz.2011.07.004. Epub 2011 Nov 2. Review.

PMID:
22047631
10.

Prevention trials in Alzheimer's disease: an EU-US task force report.

Vellas B, Aisen PS, Sampaio C, Carrillo M, Scheltens P, Scherrer B, Frisoni GB, Weiner M, Schneider L, Gauthier S, Gispen-de Wied CC, Hendrix S, Feldman H, Cedarbaum J, Petersen R, Siemers E, Andrieu S, Prvulovic D, Touchon J, Hampel H.

Prog Neurobiol. 2011 Dec;95(4):594-600. doi: 10.1016/j.pneurobio.2011.08.014. Epub 2011 Sep 10.

PMID:
21925234
11.

[A new definition for Alzheimer's disease].

Dubois B.

Bull Acad Natl Med. 2013 Jan;197(1):143-53; discussion 153-6. Review. French.

PMID:
24672986
12.
13.

Biomarkers in preclinical Alzheimer's disease.

Chong MS, Lim WS, Sahadevan S.

Curr Opin Investig Drugs. 2006 Jul;7(7):600-7. Review.

PMID:
16869111
14.

Biomarkers for Alzheimer's disease trials--biomarkers for what? A discussion paper.

Lovestone S, Thambisetty M.

J Nutr Health Aging. 2009 Apr;13(4):334-6. No abstract available.

PMID:
19300870
15.

Alzheimer's disease biomarkers: their value in diagnosis and clinical trials.

Small DH.

Front Biosci. 2002 Apr 1;7:d986-8. Review.

PMID:
11897567
17.

Global standardization measurement of cerebral spinal fluid for Alzheimer's disease: an update from the Alzheimer's Association Global Biomarkers Consortium.

Carrillo MC, Blennow K, Soares H, Lewczuk P, Mattsson N, Oberoi P, Umek R, Vandijck M, Salamone S, Bittner T, Shaw LM, Stephenson D, Bain L, Zetterberg H.

Alzheimers Dement. 2013 Mar;9(2):137-40. doi: 10.1016/j.jalz.2012.11.003. Epub 2012 Dec 28.

PMID:
23274154
18.

Biomarkers of Alzheimer's disease in body fluids.

Zheng Y, He J, Hong T.

Sci China Life Sci. 2010 Apr;53(4):490-6. doi: 10.1007/s11427-010-0081-9. Epub 2010 May 7. Review.

PMID:
20596916
19.

Disease-modifying therapies for Alzheimer disease: challenges to early intervention.

Cummings JL, Doody R, Clark C.

Neurology. 2007 Oct 16;69(16):1622-34. Review.

PMID:
17938373
20.

Revisiting the framework of the National Institute on Aging-Alzheimer's Association diagnostic criteria.

Carrillo MC, Dean RA, Nicolas F, Miller DS, Berman R, Khachaturian Z, Bain LJ, Schindler R, Knopman D; Alzheimer's Association Research Roundtable.

Alzheimers Dement. 2013 Sep;9(5):594-601. doi: 10.1016/j.jalz.2013.05.1762.

PMID:
24007744

Supplemental Content

Support Center